How can digital pharma marketers be innovative, while staying compliant, when there are no clear FDA guidelines on the way?

You need to understand FDA expectations and how to execute compliant marketing efforts by looking to the FDA’s guidance for other channels and inferring what it means for digital, all while keeping the customers’ best interests in mind.

New for 2012, the ePharma Summit has added the MLR Symposium, providing you with the tools you need to execute a responsible marketing campaign. During this full day, you’ll hear from experts that have their foot in the door and can provide insight into what the FDA is thinking, even if they can’t say anything. You will also hear from pharmaceutical companies who have built their own social media policy, en lieu of official regulatory guidance. Regulatory executives from Shire, BMS, Sanofi and Novartis will all be on-hand to answer your most pressing MLR questions including adverse event reporting, defining medial apps and compliantly working within social media outlets.

The ePharma Summit is inviting you to get up close and personal with regulatory experts from around the globe. We’ve pulled together a panel of regulatory experts who will provide you with insight into how their countries would regulate a certain campaign. If you have a hypothetical campaign that you would like to have covered, submit it to me at sgordon@iirusa.com for a chance to hear your campaign discussed.

Sessions covering regulatory issues at the ePharma Summit:

• The MLR Marketing Policy Summit (all day on Monday, February 6)
• Going Global: Examine the Digital Marketing Environment Around the World (February 8, from 3:45-4:30)

As always, if you have any questions or recommendations, please let me know.

Sarah

Sarah Gordon
ePharma Summit Conference Director
@SarahPharma

*We’re implementing a Frequently Asked ePharma Marketing Questions feature on our blog, where each week I’ll post the most common questions I came across while conducting research for ePharma.